
CAS Number117591-20-5
SynonymsZ-LEU-NLE-CHO; BENZYLOXYCARBONYLLEUCYL-NORLEUCINAL; N-Benzyloxycarbonyl-L-leucylnorieucinal Z-Leu-Nle-CHO; MFCD00155623; N-CBZ-L-LEUCYL-NORLEUCINAL; N-[(benzyloxy)carbonyl]-N-[(2S)-1-oxohexan-2-yl]-L-leucinamide; Z-Leu-Nle-H; CalpeptinN-Benzyloxycarbonyl-L-leucyl-norleucinal; CALPEPTIN; Z-LEU-NLE-OH; Z-LEU-NORLEUCINAL; Carbamic acid, N-[(1S)-1-[[[(1S)-1-formylpentyl]amino]carbonyl]-3-methylbutyl]-, phenylmethyl ester; N-BENZYLOXYCARBONYL-L-LEUCYLNORLEUCINAL; BENZYLOXYCARBONYLDIPEPTIDYL ALDEHYDE; N-benzyloxycarbonyl-L-leucyl-L-norleucinal; N-[(Benzyloxy)carbonyl]-N-[(2S)-1-oxo-2-hexanyl]-L-leucinamide
Molecular FormulaC20H30N2O4
Molecular Weight362.46
Density1.1±0.1 g/cm3
Boiling Point550.7±45.0 °C at 760 mmHg
Melting Point60-75 °C
AppearanceWhite to off-white powder
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 117591-20-5 |
| Catalog No. | 2A-1191747 |
| Chinese Name | CALPEPTIN |
| Synonyms | Z-LEU-NLE-CHO; BENZYLOXYCARBONYLLEUCYL-NORLEUCINAL; N-Benzyloxycarbonyl-L-leucylnorieucinal Z-Leu-Nle-CHO; MFCD00155623; N-CBZ-L-LEUCYL-NORLEUCINAL; N-[(benzyloxy)carbonyl]-N-[(2S)-1-oxohexan-2-yl]-L-leucinamide; Z-Leu-Nle-H; CalpeptinN-Benzyloxycarbonyl-L-leucyl-norleucinal; CALPEPTIN; Z-LEU-NLE-OH; Z-LEU-NORLEUCINAL; Carbamic acid, N-[(1S)-1-[[[(1S)-1-formylpentyl]amino]carbonyl]-3-methylbutyl]-, phenylmethyl ester; N-BENZYLOXYCARBONYL-L-LEUCYLNORLEUCINAL; BENZYLOXYCARBONYLDIPEPTIDYL ALDEHYDE; N-benzyloxycarbonyl-L-leucyl-L-norleucinal; N-[(Benzyloxy)carbonyl]-N-[(2S)-1-oxo-2-hexanyl]-L-leucinamide |
| Molecular Formula | C20H30N2O4 |
| Molecular Weight | 362.46 |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 550.7±45.0 °C at 760 mmHg |
| Melting Point | 60-75 °C |
| Appearance | White to off-white powder |
| Storage Condition | Seal and store at -20ºC |
| Application | Calpeptin is a potent, cell-penetrating calpain inhibitor with an ID50 value of 40 nM for human platelet Calpain I. Calpeptin is also an inhibitor of cathepsin K. |
| PubChem ID | 13433 |
| SMILES | CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1 |
| InChI | InChI=1S/C20H30N2O4/c1-4-5-11-17(13-23)21-19(24)18(12-15(2)3)22-20(25)26-14-16-9-7-6-8-10-16/h6-10,13,15,17-18H,4-5,11-12,14H2,1-3H3,(H,21,24)(H,22,25)/t17-,18-/m0/s1 |
| InChI Key | PGGUOGKHUUUWAF-ROUUACIJSA-N |
| Hazard Symbols | transportation |
| Bioactivity | Calpeptin is a potent, cell penetrating calpain inhibitor, with an ID50 of 40 nM for Calpain I in human platelets[1]. Calpeptin is also an inhibitor of cathepsin K[2]. Related Catalog Research Areas >> Inflammation/Immunology Signaling Pathways >> Metabolic Enzyme/Protease >> Proteasome Signaling Pathways >> Metabolic Enzyme/Protease >> Cathepsin Target ID50: 40 nM (Calpain I in human platelets)[1]. Cthepsin K[2] In Vitro Calpeptin (0-100 nM, 24 hours) treatment suppresses the proliferation of both WI38 VA13 and IMR90 cells in a dose-dependent manner. Calpeptin (1000 pg/ml, 24 hours) inhibits IL-6-induced cell proliferation of lung fibroblasts[3]. Cell Proliferation Assay[3] Cell Line: WI38 VA13 and IMR90 cells Concentration: 0-100 nM Incubation Time: 24 hours Result: Suppressed the proliferation in a dose-dependent manner. In Vivo Calpeptin with Bleo (0.04 mg/mouse, i.p., 3 times weekly, 28 days) administration significantly inhibits the collagen deposition and increases of calpain activity in the bleomycintreatedmouse lung tissues[3]. Animal Model: C57BL/6 female mice (Eight-week-old)[3]. Dosage: 0.04 mg/mouse. Administration: Intraperitoneally three times weekly for 28 days (together with Bleo). Result: Inhibited the collagen deposition and increase of calpain activity in the bleomycintreatedmouse lung tissues. References [1]. Tsujinaka T, et al. Synthesis of a new cell penetrating calpain inhibitor (calpeptin). Biochem Biophys Res Commun. 1988 Jun 30;153(3):1201-8. [2]. Catalano JG, et al. Design of small molecule ketoamide-based inhibitors of cathepsin K. Bioorg Med Chem Lett. 2004 Feb 9;14(3):719-22. [3]. Tabata C, et al. The calpain inhibitor calpeptin prevents pulmonary fibrosis in mice. Clin Exp Immunol. 2010 Dec;162(3):560-7. Chemical & Physical Properties Density 1.1±0.1 g/cm3 Boiling Point 550.7±45.0 °C at 760 mmHg Melting Point 60-75 °C Molecular Formula C20H30N2O4 Molecular Weight 362.463 Flash Point 286.8±28.7 °C Exact Mass 362.220551 PSA 84.50000 LogP 4.37 Vapour Pressure 0.0±1.5 mmHg at 25°C Index of Refraction 1.508 InChIKey PGGUOGKHUUUWAF-ROUUACIJSA-N SMILES CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1 Storage condition -20°C |
| Use of | Calpeptin is a potent, cell penetrating calpain inhibitor, with an ID50 of 40 nM for Calpain I in human platelets[1]. Calpeptin is also an inhibitor of cathepsin K[2]. Properties Articles31 Name Calpeptin,N-Benzyloxycarbonyl-L-leucylnorleucinal Synonym More Synonyms calpeptin Biological Activity Description Calpeptin is a potent, cell penetrating calpain inhibitor, with an ID50 of 40 nM for Calpain I in human platelets[1]. Calpeptin is also an inhibitor of cathepsin K[2]. Related Catalog Research Areas >> Inflammation/Immunology Signaling Pathways >> Metabolic Enzyme/Protease >> Proteasome Signaling Pathways >> Metabolic Enzyme/Protease >> Cathepsin ID50: 40 nM (Calpain I in human platelets)[1]. Cthepsin K[2] References [1]. Tsujinaka T, et al. Synthesis of a new cell penetrating calpain inhibitor (calpeptin). Biochem Biophys Res Commun. 1988 Jun 30;153(3):1201-8. [2]. Catalano JG, et al. Design of small molecule ketoamide-based inhibitors of cathepsin K. Bioorg Med Chem Lett. 2004 Feb 9;14(3):719-22. [3]. Tabata C, et al. The calpain inhibitor calpeptin prevents pulmonary fibrosis in mice. Clin Exp Immunol. 2010 Dec;162(3):560-7. Chemical & Physical Properties Molecular Formula C20H30N2O4 Exact Mass 362.220551 PSA 84.50000 Index of Refraction 1.508 InChIKey PGGUOGKHUUUWAF-ROUUACIJSA-N |
| Transport Info | Shipping Name: UN |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 United Nations shipping name European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Danger Regulations: No International Maritime Danger Regulations International Air Transport Danger Regulations: No Marine pollutants (yes/no): No 14.6 Special reminder to users No data available See reverse side of invoice or packing slip. |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| 4-(4-formylphenoxy)-3-chlorobenzonitrile | 676494-58-9 | 2A-1191742 |
| 4-Cyano-2-methoxybenzene-1-sulfonylchloride | 1261791-90-5 | 2A-1191743 |
| 2(1H)-Quinolinone, 6-amino-1,3-dimethyl- | 1425927-75-8 | 2A-1191744 |
| NI-57 | 1883548-89-7 | 2A-1191745 |
| 6-(5-carboxy-5-methyl-hexoxy)-2,2-dimethyl-hexanoic acid | 183293-82-5 | 2A-1191746 |
| GSK583 | 1346547-00-9 | 2A-1191748 |
| PH002 | 1311174-68-1 | 2A-1191749 |
| 2-(CarboxyMethyl)-4,5-diMethoxybenzoic acid | 3809-00-5 | 2A-1191751 |
| Indotecan | 915303-09-2 | 2A-1191753 |
| LMP744 | 308246-52-8 | 2A-1191754 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA